[1. Ramer LM, Ramer MS, Steeves JD. Setting the stage for functional repair of spinal cord injuries: a cast of thousands. Spinal Cord. 2005 Mar;43(3):134-61. DOI: 10.1038/sj.sc.310171510.1038/sj.sc.3101715]Search in Google Scholar
[2. Park E, Velumian AA, Fehlings MG. The role of excitotoxicity in secondary mechanisms of spinal cord injury: a review with an emphasis on the implications for white matter degeneration. Journal of Neurotrauma. 2004 Jun;21(6):754-74. DOI: 10.1089/089771504126964110.1089/0897715041269641]Search in Google Scholar
[3. Hawryluk GW, Rowland J, Kwon BK, Fehlings MG. Protection and repair of the injured spinal cord: a review of completed, ongoing, and planned clinical trials for acute spinal cord injury. Neurosurgical Focus 2008;25(5):E14. DOI: 10.3171/FOC.2008.25.11.E1410.3171/FOC.2008.25.11.E14]Search in Google Scholar
[4. Steeves JD, Lammertse D, Curt A, Fawcett JW, Tuszynski MH,Ditunno JF, et al. Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures. Spinal Cord. 2007 Mar;45(3):206-21. DOI: 10.1038/sj.sc.310200810.1038/sj.sc.3102008]Search in Google Scholar
[5. Houle JD, Tessler A. Repair of chronic spinal cord injury. Exp Neurol. 2003 Aug; 182(2): 247-60. DOI: 10.1016/S0014-4886(03)00029-310.1016/S0014-4886(03)00029-3]Search in Google Scholar
[6. Lubieniecka JM, Streijger F, Lee JHT, Stoynov N, Liu J, et al. Biomarkers for Severity of Spinal Cord Injury in the Cerebrospinal Fluid of Rats. PLoS ONE. 2011 Apr 29;6(4):e19247. DOI: 10.1371/journal.pone.001924710.1371/journal.pone.0019247]Search in Google Scholar
[7. de Vargas Ferreira VM, Varoto R, Azevedo Cacho ÊW, Cliquet A Jr. Relationship between function, strength and electromyography of upper extremities of persons with tetraplegia. Spinal Cord. 2012 Jan;50(1):28-32. DOI: 10.1038/sc.2011.9510.1038/sc.2011.95]Search in Google Scholar
[8. Freund P, Weiskopf N, Ashburner J, Wolf K, Sutter R, Altmann DR, et al. MRI investigation of the sensorimotor cortex and the corticospinal tract after acute spinal cord injury: a prospective longitudinal study. Lancet Neurol. 2013 Sep;12(9):873-81. DOI: 10.1016/S1474-4422(13)70146-710.1016/S1474-4422(13)70146-7]Search in Google Scholar
[9. Yagi M, Ninomiya K, Kihara M, Horiuchi Y. Longterm surgical outcome and risk factors in patients with cervical myelopathy and a change in signal intensity of intramedullary spinal cord on Magnetic Resonance imaging. J Neurosurg Spine. 2010 Jan;12(1):59-65. DOI: 10.3171/2009.5.SPINE0894010.3171/2009.5.SPINE0894020043766]Search in Google Scholar
[10. Lammertse D, Dungan D, Dreisbach J, Falci S, Flanders A, Marino R, et al. Neuroimaging in traumatic spinal cord injury: an evidence-based review for clinical practice and research. J Spinal Cord Med. 2007;30(3):205-14.10.1080/10790268.2007.11753928203196117684886]Search in Google Scholar
[11. Mercier E, Boutin A, Lauzier F, Fergusson DA, Simard JF, Zarychanski R, et al. Predictive value of S-100β protein for prognosis in patients with moderate and severe traumatic brain injury: systematic review and meta- analysis. BMJ. 2013 Apr 4;346:f1757.10.1136/bmj.f175723558282]Search in Google Scholar
[12. Cao F, Yang XF, Liu WG, Hu WW, Li G, Zheng XJ et al. Elevation of neuron-specific enolase and S-100beta protein level in experimental acute spinal cord injury. J Clin Neurosci. 2008 May;15(5):541-4. DOI: 10.1016/j. jocn.2007.05.014]Search in Google Scholar
[13. Pouw MH, Hosman AJ, van Middendorp JJ, Verbeek MM, Vos PE, van de Meent H. Biomarkers in spinal cord injury. Spinal Cord. 2009 Jul;47(7):519-25. DOI: 10.1038/sc.2008.17610.1038/sc.2008.17619153591]Search in Google Scholar
[14. Kwon BK, Stammers AM, Belanger LM, Bernardo A, Chan D, Bishop CM et al. Cerebrospinal fluid inflammatory cytokines and biomarkers of injury severity in acute human spinal cord injury. J Neurotrauma. 2010 Apr;27(4):669-82. DOI: 10.1089/neu.2009.108010.1089/neu.2009.108020038240]Search in Google Scholar
[15. Kamphuis W, Mamber C, Moeton M, Kooijman L, Sluijs JA, Jansen AH, et al. GFAP isoforms in adult mouse brain with a focus on neurogenic astrocytes and reactive astrogliosis in mouse models of Alzheimer disease. PLoS One. 2012 Aug;7(8):e42823. DOI: 10.1371/journal. pone.0042823]Search in Google Scholar
[16. Maas MB, Furie KL. Molecular biomarkers in stroke diagnosis and prognosis. Biomark Med. 2009 Aug 1;3(4):363-83. DOI: 10.2217/bmm.09.3010.2217/bmm.09.30277186220160867]Search in Google Scholar
[17. Shinozaki K, Oda S, Sadahiro T, Nakamura M, Hirayama Y, Abe R, et al. S-100B and neuron-specific enolase as predictors of neurological outcome in patients after cardiac arrest and return of spontaneous circulation: a systematic review. Crit Care. 2009 Jul;13(4):R121. DOI: 10.1186/cc797310.1186/cc7973275017019624826]Search in Google Scholar
[18. Shaw G, Yang C, Ellis R, Anderson K, Parker Mickle J, Scheff S et al. Hyperphosphory-lated neurofilament NF-H is a serum biomarker of axonal injury. Biochem Biophys Res Commun. 2005 Nov 4;336(4):1268-77. DOI: 10.1016/j.bbrc.2005.08.25210.1016/j.bbrc.2005.08.25216176808]Search in Google Scholar
[19. Ueno T, Ohori Y, Ito J, Hoshikawa S, Yamamoto S, Nakamura K et al. Hyperphosphory-lated neurofilament NF-H as a biomarker of the efficacy of minocycline therapy for spinal cord injury. Spinal Cord. 2011 Mar;49(3):333-6. DOI: 10.1038/sc.2010.11610.1038/sc.2010.11620805831]Search in Google Scholar
[20. Boylan KB, Glass JD, Crook JE, Yang C, Thomas CS, Desaro P, et al. Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2013 Apr;84(4):467-72. DOI: 10.1136/jnnp-2012-30376810.1136/jnnp-2012-30376823117489]Search in Google Scholar
[21. Hayakawa K, Okazaki R, Ishii K, Ueno T, Izawa N, Y Tanaka, et al. Phosphorylated neurofilament subunit NF-H as a biomarker for evaluating the severity of spinal cord injury patients, a pilot study. Spinal Cord. 2012 Jul;50(7):493-6. DOI: 10.1038/sc.2011.18410.1038/sc.2011.18422270191]Search in Google Scholar
[22. Petzold A. Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss. Journal of the Neurological Sciences 2005 Jun 15;233(1-2):183-98. DOI: 10.1016/j.jns.2005.03.01510.1016/j.jns.2005.03.01515896809]Search in Google Scholar
[23. Dileonardi AM, Huh JW, Raghupathi R. Differential effects of FK506 on structural and functional axonal deficits after diffuse brain injury in the immature rat. J Neuropathol Exp Neurol. 2012 Nov;71(11):959-72. DOI: 10.1097/NEN.0b013e31826f587610.1097/NEN.0b013e31826f5876349506023095847]Search in Google Scholar
[24. Lee JY, Kim BJ, Sim G, Kim GT, Kang D, Jung JH, et al. Spinal cord injury markedly altered protein expression patterns in the affected rat urinary bladder during healing stages. J Korean Med Sci. 2011 Jun;26(6):814-23. DOI: 10.3346/jkms.2011.26.6.81410.3346/jkms.2011.26.6.814310287821655070]Search in Google Scholar
[25. Pouw MH, Kwon BK, Verbeek MM, Vos PE, van Kampen A, Fisher CG, et al. Structural biomarkers in the cerebrospinal fluid within 24h after a traumatic spinal cord injury: a descriptive analysis of 16 subjects. Spinal Cord. 2014 Jun;52(6):428-33. DOI: 10.1038/ sc.2014.2610.1038/sc.2014.2624710150]Search in Google Scholar
[26. Petzold A, Shaw G. Comparison of two ELISA methods for measuring levels of the phosphorylated neurofilament heavy chain. J of Immunological Methods. 2007 Jan 30;319(1-2):34-40. DOI: 10.1016/j. jim.2006.09.021]Search in Google Scholar
[27. Guez M, Hildingsson C, Rosengren L, Karlsson K, Toolanen G. Nervous tissue damage markers in cerebrospinal fluid after cervical spine injuries and whiplash trauma. J Neurotrauma. 2003 Sep;20(9):853-8. DOI: 10.1089/08977150332238578210.1089/08977150332238578214577863]Search in Google Scholar
[28. Shiiya N, Kunihara T, Miyatake T, Matsuzaki K, Yasuda K. Tau protein in the cerebro-spinal fluid is a marker of brain injury after aortic surgery. Annals of Thoracic Surgery. 2004 Jun;77(6):2034-8. DOI: 10.1016/j.athoracsur. 2003.12.057]Search in Google Scholar
[29. Shen S, Loo RR, Wanner IB, Loo JA. Addressing the needs of traumatic brain injury with clinical proteomics. Clin Proteomics. 2014 Mar 28;11(1):11. DOI: 10.1186/1559-0275-11-1110.1186/1559-0275-11-11397636024678615]Search in Google Scholar
[30. Kiechle K, Bazarian JJ, Merchant-Borna K, Stoecklein V, Rozen E, Blyth B, et al. Subject-specific increases in serum S-100B distinguish sports-related concussion from sports-related exertion. PLoS One. 2014 Jan 8;9(1):e84977. DOI: 10.1371/journal.pone.0084977 10.1371/journal.pone.0084977388576524416325]Search in Google Scholar